Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
AIDS and Behavior
Erschienen in: AIDS and Behavior 5/2012

01.07.2012 | Original Paper

The Impact of Prolonged Exposure on PTSD Symptoms and Associated Psychopathology in People Living with HIV: A Randomized Test of Concept

verfasst von: Maria L. Pacella, Aaron Armelie, Jessica Boarts, Glenn Wagner, Tracy Jones, Norah Feeny, Douglas L. Delahanty

Erschienen in: AIDS and Behavior | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

People living with HIV (PLWH) report elevated levels of posttraumatic stress disorder symptoms (PTSS) and associated comorbidities. The present study tested the efficacy of prolonged exposure (PE) at reducing PTSS, depression, negative posttraumatic cognitions, and substance use in PLWH. Participants were randomly assigned to receive PE (n = 40) or to a weekly monitoring control group (n = 25). Assessments occurred at baseline, post-intervention and 3-months post-treatment. Following the 3-month assessment, controls were offered the intervention. All PE recipients (whether originally from the PE or control group) completed a 6-month assessment. Intent-to-treat mixed model repeated measures ANOVAs were conducted through 3-months post-treatment; within group analyses were conducted through 6-months. PE recipients reported fewer PTSS and negative posttraumatic cognitions and were more likely to achieve good end-state functioning; gains were maintained at 6-months. No between-group differences emerged for substance use. Overall, results support the efficacy of PE in PLWH.
Literatur
1.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
2.
Tedstone JE, Terrier N. Posttraumatic stress disorder following medical illness and treatment. Clin Psychol Rev. 2003;23:409–48.PubMedCrossRef
3.
Kelly B, Raphael B, Judd F, Kernutt G, Burnett P, Burrows G. Posttraumatic stress disorder in response to HIV infection. Gen Hosp Psychiatry. 1998;20:345–52.PubMedCrossRef
4.
Martinez A, Israelski D, Walker C, Koopman C. Posttraumatic stress disorder in women attending human immunodeficiency virus outpatient clinics. AIDS Patient Care STDs. 2002;16(6):283–91.PubMedCrossRef
5.
Safren SA, Gershuny BS, Hendriksen E. Symptoms of posttraumatic stress and death anxiety in persons with HIV and medication adherence difficulties. AIDS Patient Care STDs. 2003;17:657–64.PubMedCrossRef
6.
Theuninck AC, Lake N, Gibson S. HIV-related posttraumatic stress disorder: investigating the traumatic events. AIDS Patient Care STDs. 2010;24(8):485–91.PubMedCrossRef
7.
Pence BW, Miller WC, Whetten K, Eron JJ, Gaynes BN. Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in Southeastern United States. J Acquir Immune Defic Syndr. 2006;42(3):298–306.PubMedCrossRef
8.
Whetten K, Reif S, Ostermann J, et al. Improving health outcomes among individuals with HIV, mental illness, and substance use disorders in the Southeast. AIDS Care. 2006;18(Suppl 1):18–26.CrossRef
9.
Whetten K, Reif S, Whetten R, Murphy-McMillan LK. Trauma, mental health, distrust, and stigma among HIV-positive persons: implications for effective care. Psychosom Med. 2008;70:531–8.PubMedCrossRef
10.
Gore-Felton C, Koopman C, Speigel D. The influence of traumatic stress responses on HIV risk behavior. Presentation from the 22nd Annual Scientific Conference of the Society of Behavioral Medicine. Seattle; Feb 2001.
11.
Kimerling R, Calhoun KS, Forehand R, et al. Traumatic stress in HIV-infected women. AIDS Educ Prev. 1999;11:321–30.PubMed
12.
Reilly KH, Clark RA, Schmidt N, Benight CC, Kissinger P. The effects of post-traumatic stress disorder on HIV disease progression following hurricane Katrina. AIDS Care. 2009;21(10):1298–305.PubMedCrossRef
13.
Smith MY, Egert J, Winkel G, Jacobson J. The impact of PTSD on pain experience in persons with HIV/AIDS. Pain. 2002;98:9–17.PubMedCrossRef
14.
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–768.PubMedCrossRef
15.
Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52:1048–60.PubMedCrossRef
16.
Breslau N, Davis GC, Andreski P, Peterson E. Traumatic events and posttraumatic stress disorder in an urban population of young adults. Arch Gen Psychiatry. 1991;48:216–22.PubMedCrossRef
17.
Marshall RD, Olfson M, Hellman F, Blanco C, Guardino M, Struening EL. Comorbidity, impairment, and suicidality in subthreshold PTSD. Am J Psychiatry. 2001;158:1467–73.PubMedCrossRef
18.
Kuhn E, Blanchard EB, Fuse T, Hickling EJ, Broderick J. Heart rate of motor vehicle accident survivors in the emergency department, peritraumatic psychological reactions, ASD, and PTSD severity: a 6–month prospective study. J Trauma Stress. 2006;19(5):735–40.PubMedCrossRef
19.
Maia DB, Marmar CR, Metzler T, et al. Posttraumatic stress symptoms in an elite unit of Brazilian police officers: Prevalence and impact on psychosocial functioning and on physical and mental health. J Affect Disord. 2007;97(1):241–5.PubMedCrossRef
20.
Lauterbach D, Vora R, Rakow M. The relationship between posttraumatic stress disorder and self-reported health problems. Psychosom Med. 2005;67:939–47.PubMedCrossRef
21.
Sareen J, Cox BJ, Stein MB, Afifi TO, Fleet C, Asmundson GJG. Physical and mental comorbidity, disability, and suicidal behavior associated with posttraumatic stress disorder in a large community sample. Psychosom Med. 2007;l69:242–8.CrossRef
22.
Foa EB, Rauch SAM. Cognitive changes during prolonged exposure versus prolonged exposure plus cognitive restructuring in female assault survivors with posttraumatic stress disorder. J Counsult Clin Psychol. 2004;72(5):879–84.CrossRef
23.
Foa EB, Ehlers A, Clark DM, Tolin DF, Orsillo SM. The posttraumatic cognitions inventory (PTCI): development and validation. Psychol Assess. 1999;11(3):303–14.CrossRef
24.
Leserman J. HIV disease progression: depression, stress, and possible mechanisms. Biol Psychiatr. 2003;54(3):295–306.CrossRef
25.
Chandra PS, Desai G, Ranjan S. HIV and psychiatric disorders. Indian J Med Res. 2005;121:451–67.PubMed
26.
Cohen S, Herbert TB. Health psychology: psychological factors and physical disease from the perspective of human psychoneuroimmunology. Annu Rev Psychol. 1996;47:113–42.PubMedCrossRef
27.
Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med. 2008;70:539–45.PubMedCrossRef
28.
Leserman J, Jackson ED, Petitto JM, et al. Progression to AIDS: the effects of stress, depressive symptoms, and social support. Psychosom Med. 1999;61:397–406.PubMed
29.
Tsao JCI, Dobalian A, Moreaua C, Dobalian K. Stability of anxiety and depression in a national sample of adults with human immunodeficiency virus. J Nerv Ment Dis. 2004;192(2):111–8.PubMedCrossRef
30.
Brief DJ, Bollinger AR, Vielhauer MJ, et al. Understanding the interface of HIV, trauma, posttraumatic stress disorder, and substance use and its implications for health outcomes. AIDS Care. 2004;16(Suppl1):S97–120.PubMedCrossRef
31.
Katz S, Nevid JS. Risk factors associated with posttraumatic stress disorder symptomology in HIV-infection women. AIDS Patient Care STDs. 2005;19(2):110–20.PubMedCrossRef
32.
Delahanty DL, Bogart LM, Figler JL. Posttraumatic stress disorder symptoms, salivary cortisol, medication adherence, and CD4 levels in HIV-positive individuals. AIDS Care. 2004;16(2):247–60.PubMedCrossRef
33.
Radcliffe J, Landau Fleisher CL, Hawkins LA, et al. Posttraumatic stress and trauma history in adolescents and young adults with HIV. AIDS Patient Care STDs. 2007;21(7):501–8.PubMedCrossRef
34.
Breslau N, Davis GC, Peterson EL, Schultz L. Psychiatric sequelae of posttraumatic stress disorder in women. Arch Gen Psychiatry. 1997;54(1):81–7.PubMedCrossRef
35.
Breslau N, Kessler RC, Chilcoat SS, Schultz LR, Davis GC, Andreski P. Trauma and posttraumatic stress disorder in the community: the 1996 Detroit area survey of trauma. Arch Gen Psychiatry. 1998;55:626–32.PubMedCrossRef
36.
Keane TM, Kaloupek DG. Comorbid psychiatric disorders in PTSD: implications for research. Ann NY Acad Sci. 1997;821:24–34.PubMedCrossRef
37.
Boarts JM, Sledjeski EM, Bogart LM, Delahanty DL. The differential impact of PTSD and depression on HIV disease markers and adherence to HAART in people living with HIV. AIDS Behav. 2006;10(3):253–61.PubMedCrossRef
38.
Kalichman SC, Sikkema KJ, DiFonzi K, Luke W, Austin J. Emotional adjustment in survivors of sexual assault living with HIV-AIDS. J Trauma Stress. 2002;15(4):289–96.PubMedCrossRef
39.
Leserman J, Petitto JM, Gu H, Gaynes BN, Barroso J, Golden RN, Perkins DO, Folds JD, Evans DL. Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors. Psychol Med. 2002;32(6):1059–73.PubMedCrossRef
40.
DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101–7.PubMedCrossRef
41.
Sledjeski EM, Delahanty DL, Bogart LM. Incidence and impact of posttraumatic stress disorder and comorbid depression on adherence to HAART and CD4+ counts in people living with HIV. AIDS Patient Care STDs. 2005;19(11):728–37.PubMedCrossRef
42.
Dansky BS, Roitzsch JC, Brady KT, Saladin ME. Posttraumatic stress disorder and substance abuse: use of research in a clinical setting. J Trauma Stress. 1997;10:141–8.PubMed
43.
Breslau N, Davis GC, Schultz LR. Posttraumatic stress disorder and the incidence of nicotine, alcohol, and other drug disorders in persons who have experienced trauma. Arch Gen Psychiatry. 2003;60:289–94.PubMedCrossRef
44.
Deering CG, Glover SG, Ready D, Edelman HC, Alarcon RD. Unique patterns of comorbidity in posttraumatic stress disorder from different sources of trauma. Compr Psychiatry. 1996;37:336–46.PubMedCrossRef
45.
Friedman MJ. Biological approaches to the diagnosis and treatment of post-traumatic stress disorder. J Trauma Stress. 1991;4:67–89.CrossRef
46.
Friedman MJ, Yehuda R. Post-traumatic stress disorder and comorbidity: psychobiological approaches to differential diagnosis. In: Friedman MJ, Charney DS, editors. Neurobiological and clinical consequences of stress: from normal adaptation to post-traumatic stress disorder. Philadelphia: Lippincott-Raven Press; 2005.
47.
O’Cleirigh C, Hart TA, James CA. HIV and anxiety. In: Zvolensky MJ, Smits JA, editors. Anxiety in health behaviors and physical illness. New York: Springer Science and Business Media, LLC; 2008.
48.
Petry N. Alcohol use in HIV patients: what we don’t know may hurt us. Int J STD AIDS. 1999;10:561–70.PubMedCrossRef
49.
Crum RM, Galai N, Cohn S, Celentano DD, Vlahov D. Alcohol use and T-lymphocyte subsets among injection drug users with HIV-1 infection: a prospective analysis. Alcohol Clin Exp Res. 1996;20:364–71.PubMedCrossRef
50.
Samet JH, Horton NJ, Traphagen ET, Lyon SM, Freedberg KA. Alcohol consumption and HIV disease progression: are they related? Alcohol Clin Exp Res. 2003;27:862–7.PubMedCrossRef
51.
Myers HF, Durvasula RS. Psychiatric disorders in African American men and women living with HIV/AIDS. Cultur Divers Ethnic Minor Psychol. 1999;5(3):249–62.CrossRef
52.
Leserman J, Whetten K, Lowe K, Stangl D, Swartz MS, Thielman NM. How trauma, recent stressful events, and PTSD affect functional health status and health utilization in HIV-infected patients in the South. Psychosom Med. 2005;67:500–7.PubMedCrossRef
53.
Sloan E, Collado-Hidalgo A, Cole S. Psychobiology of HIV infection. In: Ader R, editor. Psychoneuroimmunology, volume 2. 4th ed. New York: Elsevier Academic Press; 2007.
54.
Himelhoch S, Medoff D, Oyeniyi G. Efficacy of group psychotherapy to reduce depressive symptoms among HIV-infected individuals: a systematic review and meta-analysis. AIDS Patient Care STDs. 2007;21(10):732–9.PubMedCrossRef
55.
Olatunji BO, Mimiaga MJ, O’Cleirigh C, Safren SA. A review of treatment studies of depression in HIV. Top HIV Med. 2006;14(3):112–24.PubMed
56.
Scott-Sheldon LAJ, Kalichman SC, Carey MP, Fielder RL. Stress management interventions for HIV + adults: a meta-analysis of randomized controlled trials, 1989 to 2006. Health Psychol. 2008;27(2):129–39.PubMedCrossRef
57.
Israelski DM, Prentiss DE, Lubega S, et al. Psychiatric co-morbidity in vulnerable populations receiving primary care for HIV/AIDS. AIDS Care. 2007;19((2):220–5.PubMedCrossRef
58.
Ballenger JC, Davidson JRT, Lecrubier Y, et al. Consensus statement on posttraumatic stress disorder from the international consensus group on depression and anxiety. J Clin Psychiatry. 2000;61(Suppl 5):60–6.PubMed
59.
Foa EB, Dancu CB, Hembree EA, Jaycox LH, Meadows EA, Street GPA. Comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67:194–200.PubMedCrossRef
60.
Foa EB, Keane T, Friedman M, Cohen J, editors. Effective treatments for PTSD: practice guidelines from the international society for traumatic stress studies. New York: Guilford Press; 2009.
61.
Institute of Medicine. Treatment of posttraumatic stress disorder: an assessment of the evidence. Washington: The National Academies Press; 2008; 2008.
62.
Powers MB, Halpern JM, Ferenschak MP, Gillihan SJ, Foa EB. A meta-analytic review of prolonged exposure for posttraumatic stress disorder. Clin Psychol Rev. 2010;30:635–41.PubMedCrossRef
63.
Henslee AM, Coffey SF. Exposure therapy for posttraumatic stress disorder in a residential substance use treatment facility. Prof Psychol Res Pract. 2010;41(1):34–40.CrossRef
64.
Nemeroff CB, Bremner D, Foa EB, Mayberg HS, North CS, Stein MB. Posttraumatic stress disorder: a state-of-the-science review. J Psychiatr Res. 2006;40:1–21.PubMedCrossRef
65.
Foa EB, Rothbaum BO, Riggs D, Murdock T. Treatment of PTSD in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991;59:715–23.PubMedCrossRef
66.
Foa EB, Rothbaum BO. Treating the trauma of rape. New York: The Guilford Press; 1998.
67.
Foa EB. Posttraumatic Stress Diagnostic Scale (PDS) manual. Minneapolis: National Computer Systems; 1995.
68.
First MB, Gibbon M, Spitzer RL, Williams JBW. Structured clinical interview for DSM-IV personality disorders, (SCID-II). Washington: American Psychiatric Press, Inc; 1997.
69.
Foa EB, Cashman L, Jaycox L, Perry K. The validation of a self-report measure of posttraumatic stress disorder: the posttraumatic diagnostic scale. Psychol Assess. 1997;9:445–51.CrossRef
70.
Foa EB, Riggs DS, Dancu CV, Rothbaum BO. Reliability and validity of a brief instrument for assessing post-traumatic stress disorder. J Trauma Stress. 1993;6(4):459–73.CrossRef
71.
Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psych Meas. 1997;1(3):385–401.CrossRef
72.
Jaycox LH, Foa EB, Morral AR. Influence of emotional engagement and habituation on exposure therapy for PTSD. J Consult Clin Psychol. 1998;66(1):185–92.PubMedCrossRef
73.
Bryant RA, Moulds ML, Guthrie RM, Dang ST, Nixon RDV. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003;71(4):706–12.PubMedCrossRef
74.
Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Ann Int Med. 2010;152(11):726–32.PubMed
75.
Brady KT, Dansky BS, Back SE, Foa EB, Carroll KM. Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: preliminary findings. J Subst Abuse Treat. 2001;21:47–54.PubMedCrossRef
76.
Triffleman E, Carroll K, Kellogg S. Substance dependence posttraumatic stress disorder therapy. J Subst Abuse Treat. 1999;17:3–14.PubMedCrossRef
77.
Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953–64.PubMedCrossRef
78.
van Etten ML, Taylor S. Comparative efficacy of treatments for post-traumatic stress disorder: a meta-analysis. Clin Psychol Psychother. 1998;5:126–44.CrossRef
79.
van Minnen A, Arntz A, Keijsers GPJ. Prolonged exposure in patients with chronic PTSD: predictors of treatment outcome and dropout. Behav Res Ther. 2002;40(4):439–57.PubMedCrossRef
80.
Bradley R, Greene J, Russ E, Dutra L, Westen D. A multidimensional meta-analysis of psychotherapy for PTSD. Am J Psychiatry. 2005;162(2):214–27.PubMedCrossRef
81.
Hembree EA, Foa EB, Dorfan NM, Street GP, Kowalski J, Tu X. Do patients drop out prematurely from exposure therapy for PTSD? J Trauma Stress. 2003;16(6):555–62.PubMedCrossRef
82.
Basu S, Chwastiak LA, Bruce RD. Clinical management of depression and anxiety in HIV- infected adults. AIDS. 2005;19:2057–67.PubMedCrossRef
83.
Frank LR, Knox MD, Wagganer AM. HIV/AIDS and mental disorders. In: Levin BL, Becker MA, editors. A public health prospective of women’s mental health. New York: Springer; 2010.
84.
Mugavero M, Ostermann J, Whetten K, et al. Barriers to antiretroviral adherence: the importance of depression, abuse, and other traumatic events. AIDS Patient Care STDs. 2006;20(6):418–28.PubMedCrossRef
85.
Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients. Drugs. 2006;66(6):769–89.PubMedCrossRef
86.
Cook JA, Grey D, Burke-Miller J, et al. Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in a US multi-site cohort of HIV-positive women. AIDS Care. 2006;18:93–100.PubMedCrossRef
87.
Reisner SL, Mimiaga MJ, Safren SA, Mayer KH. Stressful or traumatic life events, posttraumatic stress disorder (PTSD) symptoms, and HIV sexual risk taking among men who have sex with men. AIDS Care. 2009;29(12):1481–9.CrossRef
Metadaten
Titel
The Impact of Prolonged Exposure on PTSD Symptoms and Associated Psychopathology in People Living with HIV: A Randomized Test of Concept
verfasst von
Maria L. Pacella
Aaron Armelie
Jessica Boarts
Glenn Wagner
Tracy Jones
Norah Feeny
Douglas L. Delahanty
Publikationsdatum
01.07.2012
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 5/2012
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-011-0076-y

Weitere Artikel der Ausgabe 5/2012

AIDS and Behavior 5/2012 Zur Ausgabe

Original Paper

Syringe Coverage in an Australian Setting: Does a High Level of Syringe Coverage Moderate Syringe Sharing Behaviour?

Original Paper

NIMH Project Accept (HPTN 043) HIV/AIDS Community Mobilization (CM) to Promote Mobile HIV Voluntary Counseling and Testing (MVCT) in Rural Communities in Northern Thailand: Modifications by Experience

Original Paper

Longitudinal Effects of SafeTalk, a Motivational Interviewing-Based Program to Improve Safer Sex Practices Among People Living with HIV/AIDS

Original Paper

Streaming Weekly Soap Opera Video Episodes to Smartphones in a Randomized Controlled Trial to Reduce HIV Risk in Young Urban African American/Black Women

Original Paper

HIV Prevention Interventions for Female Sexual Partners of Injection Drug Users in Hanoi, Vietnam: 24-Month Evaluation Results

Original Paper

A Randomized Controlled Trial to Evaluate the Relative Efficacy of Enhanced Versus Standard Voluntary Counseling and Testing on Promoting Condom Use among Men Who Have Sex with Men in China

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise